cytotherapy

cytotherapy

(si?to-ther'a-pe) [? + therapeia, treatment]
1.
Hormonotherapy.
2. Use of cytotoxic or cytolytic substances or serums to treat disease.
Mentioned in ?
References in periodicals archive ?
Within its portfolio, the Company announced H-CYTE will enhance its existing cytotherapy product line, developing a disruptive technology for chronic obstructive pulmonary disease, the fourth leading cause of death in the U.S.
Jones, "Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use," Cytotherapy, vol.
Knippenberg et al., "Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure," Cytotherapy, vol.
McNiece, "Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations," Cytotherapy, vol.
Excluded studies must meet the following criteria: duplicates; patent, generic, abstracts, and reviews without specific data; in vitro or animal studies; studies about other tumors or nursing; studies with CIK cells or DC-CIK alone; studies with DC-CIK plus radiotherapy, Chinese herbs, targeted therapy, surgery, or other cytotherapy; studies with DCCIK in two groups; nonrandomized controlled studies; unrelated SR or meta-analysis; studies without data of peripheral blood lymphocytes; and studies without being included in CBM.
Hematti, "Mesenchymal stem cells in hematopoietic stem cell transplantation," Cytotherapy, vol.
There have been several reports on the use of MSCs for effective cytotherapy in diverse tumor models [11-15].
Citation: Ramasatyaveni Geesala et al., "Cox-2 inhibition potentiates mouse bone marrow stem cell engraftment and differentiation-mediated wound repair," Cytotherapy, 2017; 19 (6): 756
Citation: Asha Shekaran et al., "Biodegradable ECM-coated PCL microcarriers support scalable human early MSC expansion and in vivo bone formation," Cytotherapy, 2016; 18 (10): 1332 DOI: 10.1016/j.jcyt.2016.06.016
Allickson et al., "Bioreactors for cell therapies: Current status and future advances," Cytotherapy, vol.
Kleinsasser, "Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation," Cytotherapy, vol.
Escalante et al., "Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets," Cytotherapy, vol.